| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | DOCK2 TBC1D3E GAPVD1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D LARS1 ADGRB3 TBC1D3C TBC1D3B ARHGEF10L DOCK5 TBC1D3I TBC1D3G TBC1D3K AGAP2 TBC1D3F | 1.51e-10 | 279 | 187 | 18 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK2 TBC1D3E GAPVD1 RAPGEF6 TBC1D3 TBC1D3H TBC1D3L TBC1D3D DOCK11 LARS1 ADGRB3 PSD3 TBC1D3C TBC1D3B ARHGEF10L DOCK5 RABGEF1 TBC1D3I TBC1D3G TNS3 TBC1D3K AGAP2 TBC1D3F | 4.41e-10 | 507 | 187 | 23 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK2 TBC1D3E GAPVD1 RAPGEF6 TBC1D3 TBC1D3H TBC1D3L TBC1D3D DOCK11 LARS1 ADGRB3 PSD3 TBC1D3C TBC1D3B ARHGEF10L DOCK5 RABGEF1 TBC1D3I TBC1D3G TNS3 TBC1D3K AGAP2 TBC1D3F | 4.41e-10 | 507 | 187 | 23 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme activator activity | DOCK2 CASP8AP2 TBC1D3E GAPVD1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D LARS1 ADGRB3 PSME2 TBC1D3C TBC1D3B ARHGEF10L RHEB DOCK5 PIK3R1 MARK2 TBC1D3I TBC1D3G ALK TBC1D3K AGAP2 TBC1D3F | 1.25e-08 | 656 | 187 | 24 | GO:0008047 |
| GeneOntologyMolecularFunction | enzyme regulator activity | DOCK2 CASP8AP2 TBC1D3E GAPVD1 GBP6 RAPGEF6 TBC1D3 TBC1D3H TBC1D3L TBC1D3D DOCK11 LARS1 ADGRB3 PSD3 PSME2 TBC1D3C ELFN2 TBC1D3B ARHGEF10L RHEB DOCK5 GLMN PIK3R1 RABGEF1 C4A C4B MARK2 TBC1D3I TBC1D3G TRIB1 ALK TNS3 TBC1D3K AGAP2 TBC1D3F | 1.12e-07 | 1418 | 187 | 35 | GO:0030234 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CDK17 PCYT1A CDC42BPA RPS6KA5 TRPM7 MARK1 MARK3 MATK PTDSS1 HKDC1 CDK11A DAPK1 PGM2L1 LMTK3 ARAF CASK PIK3R1 MARK4 XYLB CDK11B MARK2 PALS2 STK38L TRIB1 ALK PCYT1B | 7.12e-07 | 938 | 187 | 26 | GO:0016772 |
| GeneOntologyMolecularFunction | kinase activity | CDK17 CDC42BPA RPS6KA5 TRPM7 MARK1 MARK3 MATK HKDC1 CDK11A DAPK1 PGM2L1 LMTK3 ARAF CASK PIK3R1 MARK4 XYLB CDK11B MARK2 PALS2 STK38L TRIB1 ALK | 8.22e-07 | 764 | 187 | 23 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CDK17 CDC42BPA RPS6KA5 TRPM7 MARK1 MARK3 MATK HKDC1 CDK11A DAPK1 PGM2L1 LMTK3 ARAF CASK PIK3R1 MARK4 XYLB CDK11B MARK2 STK38L TRIB1 ALK | 8.82e-07 | 709 | 187 | 22 | GO:0016773 |
| GeneOntologyMolecularFunction | protein serine kinase activity | CDK17 CDC42BPA RPS6KA5 TRPM7 MARK1 MARK3 CDK11A DAPK1 LMTK3 ARAF CASK MARK4 CDK11B MARK2 STK38L | 1.78e-06 | 363 | 187 | 15 | GO:0106310 |
| GeneOntologyMolecularFunction | molecular function activator activity | DOCK2 SEMA3F CASP8AP2 TBC1D3E RELN GAPVD1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D WNT3 LARS1 ADGRB3 PSME2 TBC1D3C TBC1D3B ARHGEF10L RHEB DOCK5 WNT5B PIK3R1 C1QTNF9 MARK2 TBC1D3I TBC1D3G ALK TBC1D3K AGAP2 TBC1D3F | 4.18e-06 | 1233 | 187 | 29 | GO:0140677 |
| GeneOntologyMolecularFunction | actin binding | MYH9 HDAC6 NEBL TRPM7 SYNE1 SPTB ANXA8L1 ANXA8 ACTN4 INO80 PSTPIP2 ADCY8 MICAL2 AVIL STK38L PICK1 | 1.20e-05 | 479 | 187 | 16 | GO:0003779 |
| GeneOntologyMolecularFunction | protein kinase activity | CDK17 CDC42BPA RPS6KA5 TRPM7 MARK1 MARK3 MATK CDK11A DAPK1 LMTK3 ARAF CASK MARK4 CDK11B MARK2 STK38L TRIB1 ALK | 1.46e-05 | 600 | 187 | 18 | GO:0004672 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | CDK17 CDC42BPA RPS6KA5 TRPM7 MARK1 MARK3 CDK11A DAPK1 LMTK3 ARAF CASK MARK4 CDK11B MARK2 STK38L | 2.10e-05 | 446 | 187 | 15 | GO:0004674 |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 4.77e-05 | 22 | 187 | 4 | GO:0050321 | |
| GeneOntologyMolecularFunction | actin filament binding | 5.79e-05 | 227 | 187 | 10 | GO:0051015 | |
| GeneOntologyMolecularFunction | tau protein binding | 6.85e-05 | 46 | 187 | 5 | GO:0048156 | |
| GeneOntologyMolecularFunction | choline-phosphate cytidylyltransferase activity | 8.72e-05 | 2 | 187 | 2 | GO:0004105 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH9 HDAC6 NEBL TRPM7 MARK1 MARK3 SYNE1 SPTB ANXA8L1 ANXA8 ACTN4 ANKRD23 INO80 PSTPIP2 ADCY8 MICAL2 ABRAXAS1 AVIL MARK4 PKD2 MARK2 STK38L PICK1 SNX5 | 9.83e-05 | 1099 | 187 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | benzoate-CoA ligase activity | 2.60e-04 | 3 | 187 | 2 | GO:0018858 | |
| GeneOntologyMolecularFunction | decanoate-CoA ligase activity | 5.17e-04 | 4 | 187 | 2 | GO:0102391 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.95e-04 | 18 | 187 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | phospholipid binding | PCYT1A RAPGEF6 MARK1 ANXA6 ANXA8L1 ANXA8 CPS1 PLEKHA8P1 SNX29 VNN1 AVIL PICK1 SNX5 PCYT1B | 6.77e-04 | 548 | 187 | 14 | GO:0005543 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH9 DHX37 ATP8A2 CHD9 INO80 ATAD2 ZRANB3 MMAA DNAH17 ABCC12 ACSM2A DNAH6 TOP2A ACSM2B DNAH11 | 6.92e-04 | 614 | 187 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | modified amino acid binding | 1.02e-03 | 122 | 187 | 6 | GO:0072341 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.54e-03 | 231 | 187 | 8 | GO:0005085 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.23e-03 | 28 | 187 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | magnesium ion binding | 2.34e-03 | 247 | 187 | 8 | GO:0000287 | |
| GeneOntologyMolecularFunction | fatty-acyl-CoA synthase activity | 2.35e-03 | 8 | 187 | 2 | GO:0004321 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 2.39e-03 | 194 | 187 | 7 | GO:0016705 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K AGAP2 TBC1D3F | 2.30e-10 | 109 | 182 | 12 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E RAPGEF6 TBC1D3 TBC1D3H TBC1D3L TBC1D3D DOCK11 LARS1 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K AGAP2 TBC1D3F | 4.72e-09 | 244 | 182 | 15 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E GAPVD1 RAPGEF6 TBC1D3 TBC1D3H TBC1D3L TBC1D3D DOCK11 LARS1 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TNS3 TBC1D3K AGAP2 TBC1D3F | 7.73e-09 | 335 | 182 | 17 | GO:0043087 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | CASP8AP2 TBC1D3E RELN STIM2 TRAF5 RAPGEF6 TBC1D3 HDAC6 TBC1D3H TBC1D3L TBC1D3D RPS6KA5 DOCK11 MARK3 LARS1 DAPK1 ACTN4 PSME2 DYNAP TBC1D3C TBC1D3B ADCY8 C1QTNF9 PKD2 MARK2 TBC1D3I TBC1D3G TRIB1 ALK CHTOP TNS3 TBC1D3K AGAP2 TBC1D3F | 1.01e-07 | 1430 | 182 | 34 | GO:0044093 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | CASP8AP2 TBC1D3E RAPGEF6 TBC1D3 TBC1D3H TBC1D3L TBC1D3D DOCK11 LARS1 DAPK1 PSME2 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K AGAP2 TBC1D3F | 4.82e-07 | 499 | 182 | 18 | GO:0051345 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | CASP8AP2 TBC1D3E RELN RAPGEF6 TBC1D3 TBC1D3H TBC1D3L TBC1D3D DOCK11 LARS1 DAPK1 PSME2 DYNAP TBC1D3C TBC1D3B ADCY8 C1QTNF9 MARK2 TBC1D3I TBC1D3G TRIB1 ALK CHTOP TBC1D3K AGAP2 TBC1D3F | 1.28e-06 | 1028 | 182 | 26 | GO:0043085 |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 7.59e-06 | 150 | 182 | 9 | GO:0050773 | |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | CASP8AP2 TBC1D3E GAPVD1 RAPGEF6 TBC1D3 TBC1D3H TBC1D3L TBC1D3D DOCK11 ANXA8L1 LARS1 DAPK1 ANXA8 PSME2 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TNS3 TBC1D3K AGAP2 TBC1D3F | 1.05e-05 | 878 | 182 | 22 | GO:0051336 |
| GeneOntologyBiologicalProcess | postsynapse organization | SEMA3F RELN HDAC6 RPS6KA5 MARK1 LAMA5 MFN1 RHEB CASK MARK2 STK38L PICK1 | 2.31e-05 | 313 | 182 | 12 | GO:0099173 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | DOCK2 RELN MYH9 HDAC6 CYP2J2 DOCK11 ATP8A2 WNT3 SYNE1 ADGRB3 ACTN4 INO80 PRDM7 MFN1 ARHGEF10L CASK THBS2 TINF2 WASHC5 PIK3R1 AVIL MARK4 PLA2G6 C4A C4B MARK2 ALK PICK1 | 2.57e-05 | 1366 | 182 | 28 | GO:0051130 |
| GeneOntologyBiologicalProcess | synapse organization | SEMA3F RELN HDAC6 RPS6KA5 MARK1 SPTB ADGRB3 LAMA5 ELFN2 MFN1 RHEB CASK THBS2 PTPN13 PIK3R1 MARK2 STK38L PICK1 | 3.79e-05 | 685 | 182 | 18 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell junction organization | SEMA3F RELN MYH9 HDAC6 STON1 RPS6KA5 MARK1 SPTB ADGRB3 LAMA5 ACTN4 ELFN2 MFN1 RHEB CASK THBS2 PTPN13 PIK3R1 MARK2 STK38L PLEKHA7 PICK1 | 5.06e-05 | 974 | 182 | 22 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | SEMA3F RELN RPS6KA5 MARK1 ADGRB3 MFN1 RHEB CASK THBS2 PTPN13 PIK3R1 MARK2 PICK1 | 5.15e-05 | 395 | 182 | 13 | GO:0050803 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | SEMA3F RELN TBC1D3 HDAC6 DOCK11 MARK1 ATP8A2 WNT3 SYNE1 FAT3 ADGRB3 MFN1 CASK WASHC5 PIK3R1 AVIL MARK4 ARPIN MARK2 ALK | 6.10e-05 | 846 | 182 | 20 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | SEMA3F RELN TBC1D3 HDAC6 DOCK11 MARK1 ATP8A2 WNT3 SYNE1 FAT3 ADGRB3 MFN1 CASK WASHC5 PIK3R1 AVIL MARK4 ARPIN MARK2 ALK | 8.01e-05 | 863 | 182 | 20 | GO:0031344 |
| GeneOntologyBiologicalProcess | chromatin remodeling | KDM3A HDAC6 RPS6KA5 EEF1AKMT3 TASP1 CHD9 INO80 PRDM7 ATAD2 TTF1 ZRANB3 IWS1 GLMN ZNF335 TADA2B UTY CHTOP DNMT3B | 1.03e-04 | 741 | 182 | 18 | GO:0006338 |
| GeneOntologyBiologicalProcess | negative regulation of axon extension involved in axon guidance | 1.06e-04 | 11 | 182 | 3 | GO:0048843 | |
| GeneOntologyBiologicalProcess | chromatin organization | KDM3A HDAC6 RPS6KA5 EEF1AKMT3 GPX4 TASP1 CHD9 INO80 PRDM7 ATAD2 TTF1 ZRANB3 IWS1 GLMN ABRAXAS1 ZNF335 TADA2B UTY CHTOP DNMT3B | 1.33e-04 | 896 | 182 | 20 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of synapse organization | SEMA3F RELN RPS6KA5 MARK1 ADGRB3 MFN1 RHEB CASK THBS2 PTPN13 PIK3R1 MARK2 | 1.75e-04 | 387 | 182 | 12 | GO:0050807 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | KDM3A HDAC6 RPS6KA5 EEF1AKMT3 GPX4 TASP1 CHD9 INO80 PRDM7 ATAD2 TTF1 ZRANB3 IWS1 MED15 GLMN ABRAXAS1 ZNF335 TADA2B UTY CHTOP DNMT3B | 2.05e-04 | 999 | 182 | 21 | GO:0071824 |
| GeneOntologyBiologicalProcess | negative regulation of phospholipase A2 activity | 2.31e-04 | 3 | 182 | 2 | GO:1900138 | |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 2.44e-04 | 185 | 182 | 8 | GO:0099175 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | DOCK2 MYH9 CDC42BPA HDAC6 NEBL TRPM7 SPTB ACTN4 ANKRD23 PSTPIP2 ARHGEF10L WASHC5 MICAL2 PIK3R1 AVIL ARPIN PICK1 AGAP2 | 2.77e-04 | 803 | 182 | 18 | GO:0030036 |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 3.06e-04 | 103 | 182 | 6 | GO:0048814 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | SEMA3F RELN HDAC6 MARK1 ATP8A2 WNT3 SYNE1 FAT3 ADGRB3 MFN1 CASK WASHC5 AVIL MARK2 ALK | 3.61e-04 | 612 | 182 | 15 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of axon extension involved in axon guidance | 4.20e-04 | 17 | 182 | 3 | GO:0048841 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | RELN HDAC6 DOCK11 ATP8A2 WNT3 MFN1 CASK WASHC5 PIK3R1 AVIL MARK4 MARK2 ALK | 4.61e-04 | 494 | 182 | 13 | GO:0031346 |
| GeneOntologyBiologicalProcess | actin filament-based process | DOCK2 MYH9 CDC42BPA HDAC6 NEBL TRPM7 SPTB ACTN4 ANKRD23 PSTPIP2 ARHGEF10L WASHC5 MICAL2 PIK3R1 AVIL ARPIN UTY PICK1 AGAP2 | 4.65e-04 | 912 | 182 | 19 | GO:0030029 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH9 CDC42BPA NEBL SPTB DAPK1 ACTN4 ANKRD23 PSTPIP2 ADCY8 CASK DOCK5 MICAL2 AVIL MARK2 STK38L TNS3 | 5.30e-05 | 576 | 184 | 16 | GO:0015629 |
| Domain | TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.76e-11 | 49 | 183 | 10 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 8.63e-11 | 53 | 183 | 10 | PF00566 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.27e-10 | 55 | 183 | 10 | IPR000195 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.27e-10 | 55 | 183 | 10 | PS50086 |
| Domain | MARK/par1 | 8.92e-09 | 4 | 183 | 4 | IPR033624 | |
| Domain | KA1 | 4.43e-08 | 5 | 183 | 4 | PF02149 | |
| Domain | KA1_dom | 4.43e-08 | 5 | 183 | 4 | IPR001772 | |
| Domain | KA1 | 4.43e-08 | 5 | 183 | 4 | PS50032 | |
| Domain | - | 4.43e-08 | 5 | 183 | 4 | 3.30.310.80 | |
| Domain | KA1/Ssp2_C | 3.05e-07 | 7 | 183 | 4 | IPR028375 | |
| Domain | Znf_CHHC | 9.25e-07 | 3 | 183 | 3 | IPR012996 | |
| Domain | zf-RNPHF | 9.25e-07 | 3 | 183 | 3 | PF08080 | |
| Domain | Kinase-like_dom | CDK17 CDC42BPA RPS6KA5 TRPM7 MARK1 MARK3 MATK CDK11A DAPK1 CHD9 ARAF CASK PTPN13 MARK4 CDK11B MARK2 STK38L TRIB1 ALK | 1.66e-06 | 542 | 183 | 19 | IPR011009 |
| Domain | PROTEIN_KINASE_DOM | CDK17 CDC42BPA RPS6KA5 MARK1 MARK3 MATK CDK11A DAPK1 LMTK3 ARAF CASK MARK4 CDK11B MARK2 STK38L TRIB1 ALK | 7.47e-06 | 493 | 183 | 17 | PS50011 |
| Domain | SPIN/Ssty | 9.12e-06 | 5 | 183 | 3 | IPR003671 | |
| Domain | Spin-Ssty | 9.12e-06 | 5 | 183 | 3 | PF02513 | |
| Domain | PROTEIN_KINASE_ATP | CDK17 CDC42BPA RPS6KA5 MARK1 MARK3 MATK CDK11A DAPK1 LMTK3 ARAF CASK MARK4 CDK11B MARK2 STK38L ALK | 1.23e-05 | 459 | 183 | 16 | PS00107 |
| Domain | S_TKc | CDK17 CDC42BPA RPS6KA5 MARK1 MARK3 CDK11A DAPK1 ARAF CASK MARK4 CDK11B MARK2 STK38L TRIB1 | 1.27e-05 | 359 | 183 | 14 | SM00220 |
| Domain | Pkinase | CDK17 CDC42BPA RPS6KA5 MARK1 MARK3 CDK11A DAPK1 ARAF CASK MARK4 CDK11B MARK2 STK38L TRIB1 | 2.45e-05 | 381 | 183 | 14 | PF00069 |
| Domain | Prot_kinase_dom | CDK17 CDC42BPA RPS6KA5 MARK1 MARK3 MATK CDK11A DAPK1 ARAF CASK MARK4 CDK11B MARK2 STK38L TRIB1 ALK | 2.66e-05 | 489 | 183 | 16 | IPR000719 |
| Domain | Ser/Thr_kinase_AS | CDK17 CDC42BPA RPS6KA5 MARK1 MARK3 CDK11A DAPK1 ARAF CASK MARK4 CDK11B MARK2 STK38L | 5.28e-05 | 357 | 183 | 13 | IPR008271 |
| Domain | PROTEIN_KINASE_ST | CDK17 CDC42BPA RPS6KA5 MARK1 MARK3 CDK11A DAPK1 ARAF CASK MARK4 CDK11B MARK2 STK38L | 6.08e-05 | 362 | 183 | 13 | PS00108 |
| Domain | AnnexinVIII | 9.55e-05 | 2 | 183 | 2 | IPR009115 | |
| Domain | SPIN-2 | 9.55e-05 | 2 | 183 | 2 | IPR029564 | |
| Domain | DHR-1_domain | 1.44e-04 | 11 | 183 | 3 | IPR027007 | |
| Domain | DHR_2 | 1.44e-04 | 11 | 183 | 3 | PS51651 | |
| Domain | DHR_1 | 1.44e-04 | 11 | 183 | 3 | PS51650 | |
| Domain | DHR-2 | 1.44e-04 | 11 | 183 | 3 | PF06920 | |
| Domain | DOCK | 1.44e-04 | 11 | 183 | 3 | IPR026791 | |
| Domain | DOCK_C | 1.44e-04 | 11 | 183 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 1.44e-04 | 11 | 183 | 3 | PF14429 | |
| Domain | DHR-2 | 1.44e-04 | 11 | 183 | 3 | IPR027357 | |
| Domain | UBA | 2.00e-04 | 30 | 183 | 4 | SM00165 | |
| Domain | ANX | 2.46e-04 | 13 | 183 | 3 | SM00335 | |
| Domain | Annexin_repeat_CS | 2.46e-04 | 13 | 183 | 3 | IPR018252 | |
| Domain | Annexin | 2.46e-04 | 13 | 183 | 3 | PF00191 | |
| Domain | Annexin_repeat | 2.46e-04 | 13 | 183 | 3 | IPR018502 | |
| Domain | ANNEXIN | 2.46e-04 | 13 | 183 | 3 | PS00223 | |
| Domain | - | 2.46e-04 | 13 | 183 | 3 | 1.10.220.10 | |
| Domain | P-loop_NTPase | NUGGC MYH9 GBP6 DHX37 DAPK1 CHD9 INO80 ATAD2 ZRANB3 MFN1 RHEB CASK MMAA RASD1 ABCC12 PALS2 DNAH6 CNP AGAP2 DNAH11 | 2.54e-04 | 848 | 183 | 20 | IPR027417 |
| Domain | Annexin | 3.11e-04 | 14 | 183 | 3 | IPR001464 | |
| Domain | Protein_kinase_ATP_BS | CDK17 CDC42BPA RPS6KA5 MARK1 MARK3 MATK DAPK1 ARAF MARK4 MARK2 STK38L ALK | 3.72e-04 | 379 | 183 | 12 | IPR017441 |
| Domain | - | NUGGC GBP6 DHX37 CHD9 INO80 ATAD2 ZRANB3 MFN1 RHEB CASK MMAA RASD1 ABCC12 PALS2 DNAH6 CNP AGAP2 DNAH11 | 4.00e-04 | 746 | 183 | 18 | 3.40.50.300 |
| Domain | UBA | 4.11e-04 | 36 | 183 | 4 | PF00627 | |
| Domain | UBA | 8.92e-04 | 44 | 183 | 4 | IPR015940 | |
| Domain | DOCK_N | 9.36e-04 | 5 | 183 | 2 | PF16172 | |
| Domain | DOCK_N | 9.36e-04 | 5 | 183 | 2 | IPR032376 | |
| Domain | Anaphylatoxin_comp_syst | 9.36e-04 | 5 | 183 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 9.36e-04 | 5 | 183 | 2 | IPR001840 | |
| Domain | UBA | 1.14e-03 | 47 | 183 | 4 | PS50030 | |
| Domain | SH3 | 1.33e-03 | 216 | 183 | 8 | SM00326 | |
| Domain | SH3 | 1.33e-03 | 216 | 183 | 8 | PS50002 | |
| Domain | RNA_ligase/cNuc_Pdiesterase | 1.40e-03 | 6 | 183 | 2 | IPR009097 | |
| Domain | Spectrin | 1.42e-03 | 23 | 183 | 3 | PF00435 | |
| Domain | ACTININ_2 | 1.42e-03 | 23 | 183 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.42e-03 | 23 | 183 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.42e-03 | 23 | 183 | 3 | IPR001589 | |
| Domain | SH3_domain | 1.50e-03 | 220 | 183 | 8 | IPR001452 | |
| Domain | SH3_2 | 1.57e-03 | 86 | 183 | 5 | PF07653 | |
| Domain | SH3_2 | 1.57e-03 | 86 | 183 | 5 | IPR011511 | |
| Domain | ANATO | 1.94e-03 | 7 | 183 | 2 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 1.94e-03 | 7 | 183 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 1.94e-03 | 7 | 183 | 2 | PS01177 | |
| Domain | CTP_transf_like | 1.94e-03 | 7 | 183 | 2 | PF01467 | |
| Domain | Cyt_trans-like | 1.94e-03 | 7 | 183 | 2 | IPR004821 | |
| Domain | ANATO | 1.94e-03 | 7 | 183 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 1.94e-03 | 7 | 183 | 2 | IPR000020 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 2.57e-03 | 8 | 183 | 2 | IPR019565 | |
| Domain | VPS9 | 2.57e-03 | 8 | 183 | 2 | SM00167 | |
| Domain | Thiol-ester_cl | 2.57e-03 | 8 | 183 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 2.57e-03 | 8 | 183 | 2 | IPR019742 | |
| Domain | Spectrin_repeat | 2.80e-03 | 29 | 183 | 3 | IPR002017 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K | 8.89e-07 | 99 | 147 | 9 | M46448 |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 8.56e-26 | 11 | 188 | 11 | 16863688 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RELN MYH9 CDC42BPA HDAC6 SRSF6 MARK1 DHX37 SYNE1 ZNF423 ANXA6 PTDSS1 CHD9 INO80 LMTK3 HNRNPF HNRNPH1 MYEF2 HNRNPH2 CASK IWS1 PTPN13 SUGP2 CDK11B DNMT3B SPIN3 | 1.11e-09 | 1082 | 188 | 25 | 38697112 |
| Pubmed | CDK17 GAPVD1 MIA3 RAPGEF6 HDAC6 DOCK11 MARK1 MARK3 ARAF GLMN PTPN13 RABGEF1 MARK2 STK38L PLEKHA7 SNX5 | 3.30e-09 | 446 | 188 | 16 | 24255178 | |
| Pubmed | CDK17 MYH9 MARK1 MARK3 SYNE1 SPTB PABPC4 PTDSS1 LARS1 PSD3 DAPK1 ACTN4 ELFN2 HNRNPF HNRNPH1 MYEF2 CASK SUGP2 WASHC5 MICAL2 C4A C4B MARK2 PLEKHA7 DNAH6 CNP AGAP2 DNAH11 | 4.04e-09 | 1431 | 188 | 28 | 37142655 | |
| Pubmed | KDM3A PCYT1A RELN HDAC6 STAG1 TRPM7 SYNE1 ZNF423 SPTB LARS1 ADGRB3 CUL9 CHD9 ACTN4 HNRNPF CASK PTPN13 ZNF605 MICAL2 PIK3R1 IFT122 PALS2 PICK1 SNX5 AGAP2 BRWD1 | 7.83e-09 | 1285 | 188 | 26 | 35914814 | |
| Pubmed | CDC42BPA NEBL MARK3 SYNE1 SENP3 PABPC4 PTDSS1 ASCC1 TASP1 LAMA5 CDK11A INO80 ATAD2 TTF1 ARAF MYEF2 CASK IWS1 MED15 PTPN13 GZF1 TADA2B PDCD11 MARK2 PLEKHA7 CHTOP CNP GOLGB1 | 1.07e-08 | 1497 | 188 | 28 | 31527615 | |
| Pubmed | Role of individual MARK isoforms in phosphorylation of tau at Ser²⁶² in Alzheimer's disease. | 1.23e-08 | 6 | 188 | 4 | 23666762 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KDM3A GAPVD1 RAPGEF6 HDAC6 SRSF6 RPS6KA5 MATK CDK11A ATAD2 HNRNPF HNRNPH1 CLASRP IWS1 SUGP2 TLE3 ZNF335 CDK11B MARK2 TOP2A | 4.96e-08 | 774 | 188 | 19 | 15302935 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MIA3 CDC42BPA MARK3 ANXA6 SPTB PTDSS1 CHD9 CHCHD6 TTF1 SNX29 HNRNPF CASK DOCK5 PTPN13 SUGP2 MICAL2 TLE3 PKD2 PLA2G6 IFT122 XYLB TANGO2 PALS2 STK38L GOLGB1 STEAP1 | 1.46e-07 | 1489 | 188 | 26 | 28611215 |
| Pubmed | 1.55e-07 | 3 | 188 | 3 | 14980514 | ||
| Pubmed | 1.55e-07 | 3 | 188 | 3 | 7499401 | ||
| Pubmed | 1.55e-07 | 3 | 188 | 3 | 10456323 | ||
| Pubmed | 1.55e-07 | 3 | 188 | 3 | 9108484 | ||
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 1.60e-07 | 74 | 188 | 7 | 16625196 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | GAPVD1 MYH9 RAPGEF6 TES HDAC6 MARK3 LARS1 CDK11A CHD9 INO80 FCHO1 HNRNPF HNRNPH1 CASK MED15 TLE3 MARK2 TANGO2 DNMT3B BRWD1 | 1.68e-07 | 925 | 188 | 20 | 28986522 |
| Pubmed | STIM2 RAPGEF6 MARK1 MARK3 PSD3 CASK PTPN13 PIK3R1 MARK2 PALS2 PLEKHA7 CNP GOLGB1 | 5.67e-07 | 421 | 188 | 13 | 36976175 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | NUGGC GAPVD1 DOCK11 DHX37 ASCC1 CDK11A CHD9 ARAF C4A C4B CDK11B MARK2 ANO3 CHTOP | 6.18e-07 | 497 | 188 | 14 | 36774506 |
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 6.19e-07 | 4 | 188 | 3 | 12359748 | |
| Pubmed | 6.19e-07 | 4 | 188 | 3 | 8406013 | ||
| Pubmed | MYH9 CDC42BPA SRSF6 DHX37 SENP3 PABPC4 PTDSS1 LAMA5 ACTN4 INO80 CPS1 ATAD2 SUGP2 WASHC5 PDCD11 C4A CHTOP TOP2A | 9.21e-07 | 847 | 188 | 18 | 35850772 | |
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 1.03e-06 | 190 | 188 | 9 | 15161933 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK17 GAPVD1 STIM2 RAPGEF6 CDC42BPA TRPM7 DOCK11 MARK3 MATK PSD3 ARAF PTPN13 MARK4 RABGEF1 MARK2 PLEKHA7 GOLGB1 TNS3 | 1.16e-06 | 861 | 188 | 18 | 36931259 |
| Pubmed | GAPVD1 MYH9 CDC42BPA SRSF6 NEBL MARK3 PABPC4 LARS1 ASCC1 CHD9 ACTN4 PSME2 ARAF HNRNPF HNRNPH1 MED15 MICAL2 PIK3R1 MARK2 CHTOP TOP2A TNS3 | 1.22e-06 | 1247 | 188 | 22 | 27684187 | |
| Pubmed | 1.43e-06 | 16 | 188 | 4 | 14594945 | ||
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 12604796 | ||
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 8471161 | ||
| Pubmed | GAPVD1 MYH9 STIM2 CDC42BPA HDAC6 MARK3 PABPC4 LARS1 PSD3 HNRNPF HNRNPH1 PTPN13 ARPIN MARK2 CNP GOLGB1 | 1.74e-06 | 708 | 188 | 16 | 39231216 | |
| Pubmed | 2.47e-06 | 40 | 188 | 5 | 28386764 | ||
| Pubmed | A transcriptional coregulator, SPIN·DOC, attenuates the coactivator activity of Spindlin1. | 3.07e-06 | 6 | 188 | 3 | 29061846 | |
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 4.17e-06 | 169 | 188 | 8 | 23084401 | |
| Pubmed | 4.61e-06 | 21 | 188 | 4 | 32731332 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | KDM3A PCYT1A STAG1 DHX37 GPX4 CHD9 INO80 ATAD2 IWS1 ABRAXAS1 TADA2B CDK11B TOP2A BRWD1 | 6.39e-06 | 608 | 188 | 14 | 36089195 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | CDK17 STON1 SRSF6 PABPC4 CDK11A ARAF HNRNPF HNRNPH2 CLASRP CASK MED15 SUGP2 TLE3 PDCD11 CHTOP | 6.43e-06 | 695 | 188 | 15 | 23602568 |
| Pubmed | 8.53e-06 | 8 | 188 | 3 | 22298430 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CDK17 GAPVD1 SRSF6 PTDSS1 LARS1 CDK11A CHCHD6 ACTN4 ARAF CLASRP MED15 DOCK5 PTPN13 PIK3R1 PKD2 RABGEF1 IFT122 MARK2 PLEKHA7 CNP STEAP1 | 1.07e-05 | 1321 | 188 | 21 | 27173435 |
| Pubmed | CDK17 GAPVD1 RAPGEF6 MARK3 ARAF HNRNPH1 PIK3R1 RABGEF1 STK38L | 1.13e-05 | 255 | 188 | 9 | 15324660 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | STAG1 RPS6KA5 DOCK11 ADGRB3 PSD3 CHCHD6 INO80 LMTK3 MYEF2 CASK IWS1 WASHC5 | 1.20e-05 | 475 | 188 | 12 | 31040226 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | MYH9 ANXA6 PABPC4 LARS1 ACTN4 ARAF HNRNPH1 HNRNPH2 SUGP2 TERB1 C4A C4B | 1.25e-05 | 477 | 188 | 12 | 31300519 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GAPVD1 SRSF6 SYNE1 ANXA6 PABPC4 LARS1 ACTN4 HNRNPF HNRNPH1 MYEF2 HNRNPH2 SUGP2 PDCD11 MARK2 CHTOP TOP2A CNP GOLGB1 | 1.26e-05 | 1024 | 188 | 18 | 24711643 |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | GAPVD1 MARK3 DHX37 SENP3 DAPK1 ATAD2 RHEB PTPN13 MARK2 CHTOP TOP2A | 1.27e-05 | 400 | 188 | 11 | 35013556 |
| Pubmed | 1.27e-05 | 9 | 188 | 3 | 14623875 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 1.28e-05 | 197 | 188 | 8 | 20811636 | |
| Pubmed | CDK17 HDAC6 PABPC4 ASCC1 LAMA5 CHCHD6 ACTN4 SPATA2 FCHO1 ZRANB3 ABRAXAS1 RABGEF1 | 1.35e-05 | 481 | 188 | 12 | 28190767 | |
| Pubmed | MYH9 STIM2 MIA3 CDC42BPA MARK1 ANXA8L1 ADGRB3 PSD3 ANXA8 ACTN4 ELFN2 MYEF2 HNRNPH2 RHEB SUGP2 WASHC5 RABGEF1 CHTOP AGAP2 | 1.49e-05 | 1139 | 188 | 19 | 36417873 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | STIM2 CDC42BPA TRPM7 MARK3 PSD3 DAPK1 ATAD2 CASK DOCK5 MICAL2 MARK2 PLEKHA7 TNS3 | 1.49e-05 | 569 | 188 | 13 | 30639242 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH9 HDAC6 SRSF6 DHX37 SENP3 LARS1 CHCHD6 ACTN4 ATAD2 HNRNPF HNRNPH1 MYEF2 HNRNPH2 SUGP2 WASHC5 MICAL2 PDCD11 CHTOP TOP2A CNP TNS3 | 1.52e-05 | 1353 | 188 | 21 | 29467282 |
| Pubmed | 1.62e-05 | 147 | 188 | 7 | 16959763 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | CDC42BPA DHX37 ZNF423 CPS1 HNRNPF HNRNPH1 HNRNPH2 SUGP2 CHTOP TOP2A DNMT3B | 1.64e-05 | 411 | 188 | 11 | 35182466 |
| Pubmed | 1.70e-05 | 148 | 188 | 7 | 35676246 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH9 MARK3 DHX37 SYNE1 PABPC4 PTDSS1 LARS1 CDK11A ACTN4 CPS1 HNRNPF HNRNPH1 TADA2B PDCD11 CDK11B MARK2 TOP2A | 1.75e-05 | 949 | 188 | 17 | 36574265 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CDK17 PCYT1A GAPVD1 TES HDAC6 SRSF6 STAG1 SYNE1 PABPC4 ANXA8L1 CHCHD6 ANXA8 CPS1 HNRNPF HNRNPH1 WASHC5 MARK2 CHTOP TOP2A | 1.80e-05 | 1155 | 188 | 19 | 20360068 |
| Pubmed | CDK17 CASP8AP2 STIM2 MIA3 CDC42BPA SRSF6 TRPM7 MARK3 SYNE1 PTDSS1 ASCC1 PSD3 CHCHD6 SNX29 CASK PTPN13 PIK3R1 PDCD11 IFT122 MARK2 GOLGB1 SNX5 | 1.96e-05 | 1487 | 188 | 22 | 33957083 | |
| Pubmed | 1.96e-05 | 209 | 188 | 8 | 36779422 | ||
| Pubmed | MYH9 CDC42BPA PABPC4 ACTN4 HNRNPF HNRNPH1 SUGP2 MARK2 PLEKHA7 | 2.00e-05 | 274 | 188 | 9 | 34244482 | |
| Pubmed | 14-3-3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK. | 2.03e-05 | 30 | 188 | 4 | 16306228 | |
| Pubmed | CELF4 SRSF6 PABPC4 ASCC1 HNRNPF HNRNPH1 MYEF2 HNRNPH2 PDCD11 BRWD1 | 2.13e-05 | 347 | 188 | 10 | 16033648 | |
| Pubmed | STK11 is required for the normal program of ciliated cell differentiation in airways. | 2.32e-05 | 31 | 188 | 4 | 31636950 | |
| Pubmed | GAPVD1 MYH9 STIM2 CDC42BPA STON1 TRPM7 SENP3 PABPC4 SPATA2 CASK DOCK5 PTPN13 SUGP2 ANO3 GOLGB1 | 2.37e-05 | 777 | 188 | 15 | 35844135 | |
| Pubmed | MARK1 MARK3 GPX4 ACTN4 ELFN2 ARAF CASK PTPN13 MARK4 MARK2 AGAP2 | 2.48e-05 | 430 | 188 | 11 | 32581705 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | MYH9 PABPC4 ACTN4 HNRNPF HNRNPH1 HNRNPH2 SUGP2 PDCD11 C4A CHTOP TOP2A | 2.48e-05 | 430 | 188 | 11 | 38172120 |
| Pubmed | 2.48e-05 | 11 | 188 | 3 | 20084116 | ||
| Pubmed | 2.48e-05 | 11 | 188 | 3 | 21900255 | ||
| Pubmed | Identification of an FMNL2 Interactome by Quantitative Mass Spectrometry. | 2.51e-05 | 106 | 188 | 6 | 38891874 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 2.91e-05 | 2 | 188 | 2 | 16565498 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 15998580 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 19062096 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 10480912 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 2.91e-05 | 2 | 188 | 2 | 19933335 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 7512260 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 1364010 | ||
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 2.91e-05 | 2 | 188 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 2.91e-05 | 2 | 188 | 2 | 17645767 | |
| Pubmed | Tensins are versatile regulators of Rho GTPase signalling and cell adhesion. | 2.91e-05 | 2 | 188 | 2 | 27748980 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 37399401 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 2.91e-05 | 2 | 188 | 2 | 27758680 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 22387014 | ||
| Pubmed | Cooperative binding promotes demand-driven recruitment of AnxA8 to cholesterol-containing membranes. | 2.91e-05 | 2 | 188 | 2 | 29306076 | |
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 2.91e-05 | 2 | 188 | 2 | 23749435 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 23918728 | ||
| Pubmed | Two phosphorylation-independent sites on the p85 SH2 domains bind A-Raf kinase. | 2.91e-05 | 2 | 188 | 2 | 11812000 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 2.91e-05 | 2 | 188 | 2 | 3037333 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 11726230 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 2.91e-05 | 2 | 188 | 2 | 6950384 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 2.91e-05 | 2 | 188 | 2 | 8428773 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 24638111 | ||
| Pubmed | The small RNA mascRNA differentially regulates TLR-induced proinflammatory and antiviral responses. | 2.91e-05 | 2 | 188 | 2 | 34582376 | |
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 2.91e-05 | 2 | 188 | 2 | 21345967 | |
| Pubmed | Bone matrix regulates osteoclast differentiation and annexin A8 gene expression. | 2.91e-05 | 2 | 188 | 2 | 21344395 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 21739230 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 2572548 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 2302180 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 16203777 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 2.91e-05 | 2 | 188 | 2 | 18091514 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 29080553 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 6589636 | ||
| Interaction | RAB35 interactions | GAPVD1 STIM2 CDC42BPA HDAC6 TRPM7 MARK1 MARK3 GPX4 PSD3 SNX29 HNRNPH1 MYEF2 CASK PTPN13 PIK3R1 MARK2 PLEKHA7 ALK CNP GOLGB1 | 3.13e-07 | 573 | 184 | 20 | int:RAB35 |
| Interaction | MIR17 interactions | 1.10e-06 | 85 | 184 | 8 | int:MIR17 | |
| Interaction | MIR93 interactions | 1.10e-06 | 85 | 184 | 8 | int:MIR93 | |
| Interaction | MIR20B interactions | 1.20e-06 | 86 | 184 | 8 | int:MIR20B | |
| Interaction | MIR19B2 interactions | 2.36e-06 | 94 | 184 | 8 | int:MIR19B2 | |
| Interaction | MIRLET7F1 interactions | 2.36e-06 | 94 | 184 | 8 | int:MIRLET7F1 | |
| Interaction | MIR21 interactions | 3.00e-06 | 97 | 184 | 8 | int:MIR21 | |
| Interaction | MIR363 interactions | 3.00e-06 | 97 | 184 | 8 | int:MIR363 | |
| Interaction | MIR9-3 interactions | 3.48e-06 | 70 | 184 | 7 | int:MIR9-3 | |
| Interaction | MIR128-2 interactions | 3.50e-06 | 99 | 184 | 8 | int:MIR128-2 | |
| Interaction | YWHAE interactions | CDK17 GAPVD1 STIM2 RAPGEF6 CDC42BPA HDAC6 SRSF6 TRPM7 DOCK11 MARK1 MARK3 PABPC4 LARS1 PSD3 CDK11A ACTN4 SPATA2 ARAF HNRNPH1 CASK PTPN13 PIK3R1 MARK4 CDK11B MARK2 STK38L PLEKHA7 TOP2A TBC1D3F | 3.60e-06 | 1256 | 184 | 29 | int:YWHAE |
| Interaction | MIRLET7D interactions | 4.06e-06 | 101 | 184 | 8 | int:MIRLET7D | |
| Interaction | MIR25 interactions | 4.06e-06 | 101 | 184 | 8 | int:MIR25 | |
| Interaction | MIRLET7A3 interactions | 4.38e-06 | 102 | 184 | 8 | int:MIRLET7A3 | |
| Interaction | MIR19B1 interactions | 5.06e-06 | 104 | 184 | 8 | int:MIR19B1 | |
| Interaction | MIR15A interactions | 5.55e-06 | 75 | 184 | 7 | int:MIR15A | |
| Interaction | MIRLET7E interactions | 5.83e-06 | 106 | 184 | 8 | int:MIRLET7E | |
| Interaction | MIR429 interactions | 6.06e-06 | 76 | 184 | 7 | int:MIR429 | |
| Interaction | MIR92A1 interactions | 7.22e-06 | 78 | 184 | 7 | int:MIR92A1 | |
| Interaction | MIR451A interactions | 7.22e-06 | 78 | 184 | 7 | int:MIR451A | |
| Interaction | MIR34B interactions | 7.68e-06 | 110 | 184 | 8 | int:MIR34B | |
| Interaction | MIR206 interactions | 7.86e-06 | 79 | 184 | 7 | int:MIR206 | |
| Interaction | MIR1-2 interactions | 7.86e-06 | 79 | 184 | 7 | int:MIR1-2 | |
| Interaction | MIRLET7I interactions | 1.00e-05 | 114 | 184 | 8 | int:MIRLET7I | |
| Interaction | MIR7-2 interactions | 1.18e-05 | 84 | 184 | 7 | int:MIR7-2 | |
| Interaction | MIRLET7G interactions | 1.21e-05 | 117 | 184 | 8 | int:MIRLET7G | |
| Interaction | MIR107 interactions | 1.28e-05 | 85 | 184 | 7 | int:MIR107 | |
| Interaction | MIR9-1 interactions | 1.28e-05 | 85 | 184 | 7 | int:MIR9-1 | |
| Interaction | RHOF interactions | PCYT1A STIM2 CDC42BPA HDAC6 TRPM7 DOCK11 MARK1 MARK3 PTDSS1 PSD3 ACTN4 ATAD2 RHEB CASK PTPN13 PIK3R1 MARK2 GOLGB1 TNS3 | 1.36e-05 | 673 | 184 | 19 | int:RHOF |
| Interaction | MIR29A interactions | 1.49e-05 | 87 | 184 | 7 | int:MIR29A | |
| Interaction | MIR138-2 interactions | 1.61e-05 | 88 | 184 | 7 | int:MIR138-2 | |
| Interaction | MIR29C interactions | 1.73e-05 | 89 | 184 | 7 | int:MIR29C | |
| Interaction | MIR221 interactions | 1.86e-05 | 90 | 184 | 7 | int:MIR221 | |
| Interaction | MIR92A2 interactions | 1.86e-05 | 90 | 184 | 7 | int:MIR92A2 | |
| Interaction | MIR1-1 interactions | 1.86e-05 | 90 | 184 | 7 | int:MIR1-1 | |
| Interaction | MIR214 interactions | 2.31e-05 | 93 | 184 | 7 | int:MIR214 | |
| Interaction | MIR205 interactions | 2.31e-05 | 93 | 184 | 7 | int:MIR205 | |
| Interaction | MIRLET7F2 interactions | 3.03e-05 | 97 | 184 | 7 | int:MIRLET7F2 | |
| Interaction | YWHAQ interactions | CDK17 MYH9 RAPGEF6 CDC42BPA HDAC6 SRSF6 TRPM7 DOCK11 MARK1 MARK3 SPTB PABPC4 PSD3 DAPK1 CPS1 ARAF HNRNPF HNRNPH1 PTPN13 RABGEF1 CDK11B MARK2 PLEKHA7 GOLGB1 TNS3 | 3.11e-05 | 1118 | 184 | 25 | int:YWHAQ |
| Interaction | MIR106B interactions | 3.24e-05 | 98 | 184 | 7 | int:MIR106B | |
| Interaction | EPHA2 interactions | CDK17 STIM2 RAPGEF6 TES HDAC6 MARK1 MARK3 PSD3 PSME2 ARAF CASK PTPN13 PIK3R1 MARK2 PALS2 PLEKHA7 ALK CNP GOLGB1 | 3.37e-05 | 719 | 184 | 19 | int:EPHA2 |
| Interaction | RAC1 interactions | DOCK2 PCYT1A MYH9 CDC42BPA HDAC6 TRPM7 DOCK11 MARK3 PTDSS1 PSD3 RELB ELFN2 RHEB CASK DOCK5 PTPN13 PIK3R1 MARK2 TOP2A CNP PICK1 TNS3 AGAP2 TBC1D3F | 3.91e-05 | 1063 | 184 | 24 | int:RAC1 |
| Interaction | RNF43 interactions | GAPVD1 STIM2 MIA3 TES PABPC4 PTDSS1 HNRNPF HNRNPH1 HNRNPH2 PTPN13 SUGP2 PIK3R1 PLEKHA7 GOLGB1 | 3.98e-05 | 427 | 184 | 14 | int:RNF43 |
| Interaction | MIR15B interactions | 4.47e-05 | 103 | 184 | 7 | int:MIR15B | |
| Interaction | MIR7-1 interactions | 4.47e-05 | 103 | 184 | 7 | int:MIR7-1 | |
| Interaction | MIR29B2 interactions | 4.67e-05 | 71 | 184 | 6 | int:MIR29B2 | |
| Interaction | MIR34A interactions | 4.75e-05 | 104 | 184 | 7 | int:MIR34A | |
| Interaction | MIR29B1 interactions | 5.47e-05 | 73 | 184 | 6 | int:MIR29B1 | |
| Interaction | MIR20A interactions | 5.91e-05 | 74 | 184 | 6 | int:MIR20A | |
| Interaction | MIRLET7A1 interactions | 6.05e-05 | 108 | 184 | 7 | int:MIRLET7A1 | |
| Interaction | MIR16-1 interactions | 6.87e-05 | 76 | 184 | 6 | int:MIR16-1 | |
| Interaction | MIR200A interactions | 7.40e-05 | 77 | 184 | 6 | int:MIR200A | |
| Interaction | MIR143 interactions | 9.16e-05 | 80 | 184 | 6 | int:MIR143 | |
| Interaction | GSK3A interactions | GAPVD1 MIA3 RAPGEF6 HDAC6 STON1 MARK3 PABPC4 ACTN4 SNX29 PTPN13 SUGP2 MARK2 CHTOP TNS3 | 9.68e-05 | 464 | 184 | 14 | int:GSK3A |
| Interaction | ZBTB20 interactions | 1.10e-04 | 52 | 184 | 5 | int:ZBTB20 | |
| Interaction | MIR106A interactions | 1.13e-04 | 83 | 184 | 6 | int:MIR106A | |
| Interaction | MECP2 interactions | RELN MYH9 CDC42BPA HDAC6 SRSF6 MARK1 DHX37 SYNE1 ZNF423 ANXA6 PTDSS1 CHD9 INO80 LMTK3 HNRNPF HNRNPH1 MYEF2 HNRNPH2 CASK IWS1 PTPN13 SUGP2 PDCD11 CDK11B DNMT3B SPIN3 | 1.15e-04 | 1287 | 184 | 26 | int:MECP2 |
| Interaction | MIR199A1 interactions | 1.20e-04 | 84 | 184 | 6 | int:MIR199A1 | |
| Interaction | MIR31 interactions | 1.20e-04 | 84 | 184 | 6 | int:MIR31 | |
| Interaction | MIR16-2 interactions | 1.28e-04 | 85 | 184 | 6 | int:MIR16-2 | |
| Interaction | C11orf52 interactions | CDC42BPA MARK1 MARK3 PSD3 CASK PTPN13 PIK3R1 MARK2 PALS2 PLEKHA7 CNP | 1.41e-04 | 311 | 184 | 11 | int:C11orf52 |
| Interaction | YWHAB interactions | CDK17 GAPVD1 STIM2 RAPGEF6 CDC42BPA TRPM7 DOCK11 MARK1 MARK3 PABPC4 PSD3 DAPK1 ARAF PTPN13 MARK4 RABGEF1 CDK11B MARK2 STK38L PLEKHA7 TNS3 AGAP2 | 1.49e-04 | 1014 | 184 | 22 | int:YWHAB |
| Interaction | CDH19 interactions | 1.53e-04 | 30 | 184 | 4 | int:CDH19 | |
| Interaction | ANXA8L1 interactions | 1.55e-04 | 12 | 184 | 3 | int:ANXA8L1 | |
| Interaction | RAC2 interactions | DOCK2 PCYT1A STIM2 CDC42BPA TRPM7 DOCK11 MARK3 PTDSS1 PSD3 SNX29 CASK DOCK5 PIK3R1 MARK2 GOLGB1 TNS3 AGAP2 | 1.55e-04 | 674 | 184 | 17 | int:RAC2 |
| Interaction | MIR141 interactions | 1.56e-04 | 88 | 184 | 6 | int:MIR141 | |
| Interaction | DSCAM interactions | 1.80e-04 | 171 | 184 | 8 | int:DSCAM | |
| Interaction | MIR200C interactions | 1.87e-04 | 91 | 184 | 6 | int:MIR200C | |
| Interaction | MIR155 interactions | 1.99e-04 | 92 | 184 | 6 | int:MIR155 | |
| Interaction | MIR128-1 interactions | 1.99e-04 | 92 | 184 | 6 | int:MIR128-1 | |
| Interaction | OCLN interactions | MIA3 RAPGEF6 CDC42BPA TRPM7 MARK3 PSD3 CASK PTPN13 PIK3R1 C4A MARK2 PLEKHA7 GOLGB1 SNX5 | 2.10e-04 | 500 | 184 | 14 | int:OCLN |
| Interaction | MIRLET7A2 interactions | 2.51e-04 | 96 | 184 | 6 | int:MIRLET7A2 | |
| Interaction | PRDM7 interactions | 2.53e-04 | 14 | 184 | 3 | int:PRDM7 | |
| Interaction | MIRLET7C interactions | 2.65e-04 | 97 | 184 | 6 | int:MIRLET7C | |
| Interaction | SNTB1 interactions | 2.75e-04 | 63 | 184 | 5 | int:SNTB1 | |
| Interaction | CLIC3 interactions | 2.75e-04 | 63 | 184 | 5 | int:CLIC3 | |
| Interaction | TERF2 interactions | MYH9 SRSF6 MARK3 DHX37 SYNE1 PABPC4 HNRNPH1 CLASRP TINF2 TADA2B TOP2A | 3.03e-04 | 340 | 184 | 11 | int:TERF2 |
| Interaction | EPB41L4A interactions | 3.05e-04 | 140 | 184 | 7 | int:EPB41L4A | |
| Interaction | DMD interactions | 3.19e-04 | 141 | 184 | 7 | int:DMD | |
| Interaction | ACTN4 interactions | MYH9 TES HDAC6 STAG1 PABPC4 DAPK1 ACTN4 INO80 HNRNPH1 MYEF2 ALK AGAP2 | 3.23e-04 | 400 | 184 | 12 | int:ACTN4 |
| Interaction | DTNB interactions | 3.30e-04 | 101 | 184 | 6 | int:DTNB | |
| Interaction | MIRLET7B interactions | 3.30e-04 | 101 | 184 | 6 | int:MIRLET7B | |
| Interaction | SNTB2 interactions | 3.47e-04 | 143 | 184 | 7 | int:SNTB2 | |
| Interaction | KCTD13 interactions | CDK17 MYH9 MARK1 MARK3 SYNE1 SPTB PABPC4 PTDSS1 LARS1 PSD3 DAPK1 ACTN4 ELFN2 HNRNPF HNRNPH1 MYEF2 CASK SUGP2 WASHC5 MICAL2 MARK2 PLEKHA7 DNAH6 CNP AGAP2 DNAH11 | 4.01e-04 | 1394 | 184 | 26 | int:KCTD13 |
| Interaction | DSCR9 interactions | 4.10e-04 | 147 | 184 | 7 | int:DSCR9 | |
| Interaction | YWHAZ interactions | CDK17 GAPVD1 MYH9 STIM2 RAPGEF6 CDC42BPA HDAC6 RPS6KA5 TRPM7 DOCK11 MARK1 MARK3 PABPC4 PSD3 SPATA2 ARAF RHEB PTPN13 PIK3R1 MARK4 RABGEF1 CDK11B MARK2 PLEKHA7 CNP | 4.13e-04 | 1319 | 184 | 25 | int:YWHAZ |
| Interaction | CDC42 interactions | PCYT1A STIM2 CDC42BPA HDAC6 RPS6KA5 TRPM7 DOCK11 MARK3 SYNE1 PABPC4 PTDSS1 LARS1 PSD3 HNRNPH1 CASK PTPN13 PIK3R1 MARK4 MARK2 PLEKHA7 CNP GOLGB1 PICK1 AGAP2 TBC1D3F | 4.32e-04 | 1323 | 184 | 25 | int:CDC42 |
| Interaction | FBXO22 interactions | NUGGC GAPVD1 DOCK11 DHX37 ASCC1 CDK11A CHD9 ARAF C4A C4B CDK11B MARK2 ANO3 CHTOP | 4.56e-04 | 540 | 184 | 14 | int:FBXO22 |
| Interaction | MIR122 interactions | 4.80e-04 | 71 | 184 | 5 | int:MIR122 | |
| Interaction | ACSM2A interactions | 4.91e-04 | 4 | 184 | 2 | int:ACSM2A | |
| Interaction | ACSM2B interactions | 4.91e-04 | 4 | 184 | 2 | int:ACSM2B | |
| Interaction | LTK interactions | 5.02e-04 | 152 | 184 | 7 | int:LTK | |
| Interaction | EEF1AKMT3 interactions | GAPVD1 RPS6KA5 EEF1AKMT3 PSD3 CDK11A CUL9 RELB ARAF DOCK5 IFT122 CDK11B | 5.38e-04 | 364 | 184 | 11 | int:EEF1AKMT3 |
| Interaction | MIR18A interactions | 5.46e-04 | 73 | 184 | 5 | int:MIR18A | |
| Interaction | AKT1 interactions | MYH9 HDAC6 RPS6KA5 EEF1AKMT3 MATK ARAF HNRNPH1 IWS1 PIK3R1 ABRAXAS1 MARK4 PKD2 MARK2 PICK1 AGAP2 | 5.60e-04 | 617 | 184 | 15 | int:AKT1 |
| Interaction | PRKD2 interactions | 5.62e-04 | 254 | 184 | 9 | int:PRKD2 | |
| Interaction | MARK1 interactions | 5.81e-04 | 74 | 184 | 5 | int:MARK1 | |
| Interaction | CXADR interactions | STIM2 CDC42BPA NEBL MARK1 MARK3 PSD3 PTPN13 PIK3R1 MARK2 CNP GOLGB1 | 6.03e-04 | 369 | 184 | 11 | int:CXADR |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.42e-11 | 149 | 188 | 11 | chr17q12 |
| Cytoband | 22q13.1 | 2.75e-05 | 85 | 188 | 5 | 22q13.1 | |
| Cytoband | 17q12 | 5.72e-05 | 99 | 188 | 5 | 17q12 | |
| Cytoband | Xp11.1 | 9.95e-05 | 4 | 188 | 2 | Xp11.1 | |
| Cytoband | 12q14.1 | 2.05e-04 | 28 | 188 | 3 | 12q14.1 | |
| Cytoband | 8q24.13 | 4.37e-04 | 36 | 188 | 3 | 8q24.13 | |
| Cytoband | 18q12 | 1.26e-03 | 13 | 188 | 2 | 18q12 | |
| GeneFamily | Tudor domain containing|Spindlin family | 3.59e-06 | 5 | 130 | 3 | 1089 | |
| GeneFamily | Annexins|Endogenous ligands | 9.86e-05 | 13 | 130 | 3 | 404 | |
| GeneFamily | Dyneins, axonemal | 2.29e-04 | 17 | 130 | 3 | 536 | |
| GeneFamily | Cyclin dependent kinases | 8.37e-04 | 26 | 130 | 3 | 496 | |
| GeneFamily | RNA binding motif containing | 8.87e-04 | 213 | 130 | 7 | 725 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.79e-03 | 9 | 130 | 2 | 1234 | |
| GeneFamily | VPS9 domain containing | 2.22e-03 | 10 | 130 | 2 | 928 | |
| GeneFamily | Tudor domain containing | 2.36e-03 | 37 | 130 | 3 | 780 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | DOCK2 MYH9 RAPGEF6 CDC42BPA HDAC6 ACTN4 MARK4 PKD2 STK38L TOP2A | 1.70e-06 | 199 | 186 | 10 | M5893 |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5 | PCYT1A MYH9 TRAF5 MIA3 NEBL DOCK11 PSD3 PTPN13 SC5D WASHC5 PKD2 RASD1 STK38L PLEKHA7 BRWD1 | 2.51e-06 | 491 | 186 | 15 | M13661 |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_UP | TRAF5 MIA3 NEBL CYP2J2 DOCK11 MARK1 WNT3 PSTPIP2 MMAA DOCK5 PTPN13 TADA2B RASD1 STK38L PLEKHA7 TNS3 | 4.53e-06 | 583 | 186 | 16 | M17454 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | RELN CELF4 TES TBC1D3 MARK1 ATP8A2 FAT3 DAPK1 PGM2L1 LMTK3 ELFN2 ADCY8 MYEF2 PIK3R1 PHYHIPL | 1.98e-05 | 584 | 186 | 15 | M39068 |
| Coexpression | HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR | 3.38e-05 | 52 | 186 | 5 | M1543 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F DNMT3B | 6.51e-09 | 90 | 186 | 10 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B ARPIN TBC1D3G TBC1D3K TBC1D3F | 1.92e-05 | 213 | 186 | 10 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B ARPIN TBC1D3G TBC1D3K TBC1D3F | 1.92e-05 | 213 | 186 | 10 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | TRAF5 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 5.69e-05 | 242 | 186 | 10 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | NEBL DOCK11 SYNE1 FAT3 DAPK1 C8orf34 DNAH17 PHYHIPL TNS3 DNAH11 | 4.24e-09 | 176 | 188 | 10 | 327a3e81b724252e36d786de92a3ffd721ea6d7b |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | NEBL DOCK11 SYNE1 FAT3 DAPK1 C8orf34 DNAH17 PHYHIPL TNS3 DNAH11 | 4.48e-09 | 177 | 188 | 10 | da8802a6351d3e510822f82e2fde8a4314a2216e |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.11e-08 | 181 | 188 | 9 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | NEBL DOCK11 FAT3 DAPK1 C8orf34 ARHGEF10L DNAH17 PHYHIPL TNS3 | 8.91e-08 | 183 | 188 | 9 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-07 | 188 | 188 | 9 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-07 | 189 | 188 | 9 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.17e-07 | 189 | 188 | 9 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.58e-07 | 170 | 188 | 8 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.58e-07 | 170 | 188 | 8 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-06 | 181 | 188 | 8 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-06 | 182 | 188 | 8 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-06 | 183 | 188 | 8 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 184 | 188 | 8 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 189 | 188 | 8 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-06 | 191 | 188 | 8 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.15e-06 | 199 | 188 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.73e-06 | 175 | 188 | 7 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Itih5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.96e-06 | 116 | 188 | 6 | 605bd4fdf547cc41783e99cd78425760ef6461ef | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 119 | 188 | 6 | c3f1223356e7f245a460ea5568a223e34e458dc1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 182 | 188 | 7 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.30e-05 | 183 | 188 | 7 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 183 | 188 | 7 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 1.35e-05 | 184 | 188 | 7 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 186 | 188 | 7 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.50e-05 | 187 | 188 | 7 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 187 | 188 | 7 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.55e-05 | 188 | 188 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 1.60e-05 | 189 | 188 | 7 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 191 | 188 | 7 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 193 | 188 | 7 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 193 | 188 | 7 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.89e-05 | 194 | 188 | 7 | b0a7f5ca0c6f4f5764a8b35b5de80d82b828c66c | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.96e-05 | 195 | 188 | 7 | c750602c765a51075ba6ede78e3ba80b62374481 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytotoxic_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.96e-05 | 195 | 188 | 7 | 730c613cf6f4d16ca51fd44de1f5a883f615c5c5 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.02e-05 | 196 | 188 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 196 | 188 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.02e-05 | 196 | 188 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 197 | 188 | 7 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-05 | 197 | 188 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-05 | 199 | 188 | 7 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-05 | 199 | 188 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.23e-05 | 199 | 188 | 7 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-TNFAIP8L3-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.30e-05 | 200 | 188 | 7 | 978dfb3c1d5e1c3d778a089175c50b8b719626c0 | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.30e-05 | 200 | 188 | 7 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-TNFAIP8L3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.30e-05 | 200 | 188 | 7 | d28b27776c46054b01bdd1e0f1db7c5cd5a48b88 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature_2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.27e-05 | 143 | 188 | 6 | abe6ec0f6956b87f394d537926eb2427fcfad93f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 5.50e-05 | 157 | 188 | 6 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-05 | 158 | 188 | 6 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-05 | 158 | 188 | 6 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.55e-05 | 162 | 188 | 6 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.54e-05 | 170 | 188 | 6 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.11e-05 | 172 | 188 | 6 | 80b565f6e37f38629f4cf89d5b053b3b8517244e | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 9.41e-05 | 173 | 188 | 6 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1-2_PAX6_SCGN|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.41e-05 | 173 | 188 | 6 | 33170a1cc0bc87504d0501fc257a32ff17e02314 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.00e-04 | 175 | 188 | 6 | 8fb8c4b9e2d9b7d737f59cd9bd3dc2bca5a8dfc4 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 175 | 188 | 6 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 176 | 188 | 6 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 178 | 188 | 6 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-04 | 180 | 188 | 6 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-04 | 180 | 188 | 6 | 557453b74d4a9cc95ed1c7b9a9a58e45eb02ed6a | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 180 | 188 | 6 | 87347af8f28cf7c486c19f3f98c0afb022c323b5 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-04 | 180 | 188 | 6 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-04 | 180 | 188 | 6 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 181 | 188 | 6 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 181 | 188 | 6 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 181 | 188 | 6 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 181 | 188 | 6 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 182 | 188 | 6 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-04 | 182 | 188 | 6 | 8ccffcbae28c374fd4161fb0d4cf2c49fae557f6 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 1.28e-04 | 183 | 188 | 6 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | IPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 1.28e-04 | 183 | 188 | 6 | 7df20e3172a1220ff427f30181f4f0c3b7fe2d42 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.32e-04 | 184 | 188 | 6 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.36e-04 | 185 | 188 | 6 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-04 | 186 | 188 | 6 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | ASK440-Immune-T_cell|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.44e-04 | 187 | 188 | 6 | a260c5e0d1442a2ac6329af3eb11193a33bd4671 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-04 | 187 | 188 | 6 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.48e-04 | 188 | 188 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.48e-04 | 188 | 188 | 6 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.48e-04 | 188 | 188 | 6 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | COPD-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 1.48e-04 | 188 | 188 | 6 | 159d63ecc3653a7449fc6acefd6ef0464845260e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 189 | 188 | 6 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 189 | 188 | 6 | 1ecf9911ff82e0ca0f0c101b735d3b1f3b339d57 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-|bone_marrow / Manually curated celltypes from each tissue | 1.53e-04 | 189 | 188 | 6 | 6e402fb3fc31e4cb541e3cd140d7a86c1083dbf5 | |
| ToppCell | Hippocampus-Neuronal-Excitatory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.53e-04 | 189 | 188 | 6 | 4b90d181eb0a42814eeb23bc82e52fd3a12392a7 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.57e-04 | 190 | 188 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | pdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.57e-04 | 190 | 188 | 6 | b05db0de9b6ae01dd30074453f7de44f7397631e | |
| ToppCell | ASK454-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.57e-04 | 190 | 188 | 6 | 5cea6480f08253d7adf484e511d3fdfa96641268 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 190 | 188 | 6 | a5db902ad112a0c0a0a7f1a2e38718bb3bd11412 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.61e-04 | 191 | 188 | 6 | b2d0ea24970da09209da9d9dda76e30fbfe22917 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-04 | 191 | 188 | 6 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-04 | 191 | 188 | 6 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.61e-04 | 191 | 188 | 6 | de54dab85db70f847de75b3b6d7667a0e13b9bfb | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.61e-04 | 191 | 188 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 1.61e-04 | 191 | 188 | 6 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 193 | 188 | 6 | 3091090abcf18b48eac7e6c85653c18aa54fcb9b | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.71e-04 | 193 | 188 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Stem_cells-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 193 | 188 | 6 | a18770ceb770aaa4903dd04442ad0a73159ead9a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-04 | 194 | 188 | 6 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_bright-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.76e-04 | 194 | 188 | 6 | dc4aeee379423827e8d291cffe4dbdf2ff6d0bbe | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-04 | 194 | 188 | 6 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| Disease | visual impairment and progressive phthisis bulbi (implicated_via_orthology) | 1.20e-09 | 4 | 175 | 4 | DOID:0070356 (implicated_via_orthology) | |
| Disease | coronary artery disease | ANKRD31 MIA3 STON1 STAG1 TRPM7 MARK3 WNT3 PSD3 INO80 SPATA2 C8orf34 FCHO1 DOCK5 GLMN ZNF335 MARK4 PLEKHA7 TRIB1 ALK TNS3 | 2.97e-05 | 1194 | 175 | 20 | EFO_0001645 |
| Disease | X-21319 measurement | 3.50e-05 | 2 | 175 | 2 | EFO_0800807 | |
| Disease | fibrinogen measurement, coronary artery disease | 3.91e-05 | 154 | 175 | 7 | EFO_0001645, EFO_0004623 | |
| Disease | X-11478 measurement | 1.05e-04 | 3 | 175 | 2 | EFO_0021242 | |
| Disease | Bone Marrow Diseases | 1.05e-04 | 3 | 175 | 2 | C0005956 | |
| Disease | Malignant neoplasm of salivary gland | 1.47e-04 | 45 | 175 | 4 | C0220636 | |
| Disease | Salivary Gland Neoplasms | 1.75e-04 | 47 | 175 | 4 | C0036095 | |
| Disease | mean fractional anisotropy measurement | 2.61e-04 | 95 | 175 | 5 | EFO_0008399 | |
| Disease | fatty acid measurement | ANKRD31 STAG1 ATP8A2 PABPC4 PSD3 RELB PIK3R1 RASD1 TRIB1 BRWD1 | 2.94e-04 | 436 | 175 | 10 | EFO_0005110 |
| Disease | Ischemic stroke, fibrinogen measurement | 3.22e-04 | 55 | 175 | 4 | EFO_0004623, HP_0002140 | |
| Disease | Ovarian Serous Adenocarcinoma | 3.33e-04 | 23 | 175 | 3 | C1335177 | |
| Disease | 3-hydroxyhexanoate measurement | 3.46e-04 | 5 | 175 | 2 | EFO_0800378 | |
| Disease | sleep duration, triglyceride measurement | 3.97e-04 | 104 | 175 | 5 | EFO_0004530, EFO_0005271 | |
| Disease | executive function measurement | 4.34e-04 | 376 | 175 | 9 | EFO_0009332 | |
| Disease | level of Sterol ester (27:1/18:2) in blood serum | 4.82e-04 | 26 | 175 | 3 | OBA_2045194 | |
| Disease | indoleacetoylcarnitine measurement | 5.16e-04 | 6 | 175 | 2 | EFO_0800106 | |
| Disease | reticulocyte count | SEMA3F MYH9 SPTB TKTL1 ADCY8 DOCK5 MICAL2 PIK3R1 DNAH17 MARK4 SPIN2A PLA2G6 C4B PLEKHA7 TRIB1 TNS3 | 5.18e-04 | 1045 | 175 | 16 | EFO_0007986 |
| Disease | Neural crest tumor | 7.20e-04 | 7 | 175 | 2 | C2931189 | |
| Disease | Cerebellar Diseases | 7.20e-04 | 7 | 175 | 2 | C0007760 | |
| Disease | gout | 1.15e-03 | 196 | 175 | 6 | EFO_0004274 | |
| Disease | mean platelet volume | SEMA3F PCYT1A MYH9 SRSF6 DOCK11 PSD3 CHD9 ACTN4 CPS1 DOCK5 MARK4 ARPIN STK38L PICK1 SPIN3 | 1.16e-03 | 1020 | 175 | 15 | EFO_0004584 |
| Disease | serine measurement | 1.17e-03 | 35 | 175 | 3 | EFO_0009774 | |
| Disease | ureteral obstruction (implicated_via_orthology) | 1.23e-03 | 9 | 175 | 2 | DOID:5199 (implicated_via_orthology) | |
| Disease | calcium measurement | ANKRD31 STIM2 PSD3 ANKRD23 CPS1 TLE3 MARK4 ABCC12 FER1L5 TRIB1 GOLGB1 | 1.38e-03 | 628 | 175 | 11 | EFO_0004838 |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 1.48e-03 | 206 | 175 | 6 | EFO_0004612, EFO_0020947 | |
| Disease | alpha wave measurement, electroencephalogram measurement | 1.53e-03 | 10 | 175 | 2 | EFO_0004357, EFO_0006870 | |
| Disease | reticulocyte measurement | SEMA3F MYH9 SPTB ACTN4 TKTL1 ADCY8 DOCK5 MICAL2 PIK3R1 DNAH17 MARK4 SPIN2A PLEKHA7 TRIB1 TNS3 | 1.59e-03 | 1053 | 175 | 15 | EFO_0010700 |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.72e-03 | 144 | 175 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.77e-03 | 145 | 175 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | Glioma | 1.81e-03 | 87 | 175 | 4 | C0017638 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.83e-03 | 291 | 175 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | cognitive decline measurement, memory performance, language measurement | 1.86e-03 | 11 | 175 | 2 | EFO_0004874, EFO_0007710, EFO_0007797 | |
| Disease | serum alanine aminotransferase measurement | RAPGEF6 STON1 STAG1 TRPM7 MARK3 LAMA5 HKDC1 CPS1 PIK3R1 MARK4 PLA2G6 TRIB1 BRWD1 | 2.12e-03 | 869 | 175 | 13 | EFO_0004735 |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 2.14e-03 | 91 | 175 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | C-reactive protein measurement | SEMA3F PCYT1A TES ANXA6 PABPC4 PSD3 RELB CCDC168 ADCY8 CLASRP GLMN DNAH17 MARK4 PLA2G6 TRIB1 DNAH11 | 2.29e-03 | 1206 | 175 | 16 | EFO_0004458 |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.31e-03 | 225 | 175 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | creatinine measurement | GAPVD1 STAG1 LAMA5 CHD9 INO80 CPS1 GLMN PIK3R1 PKD2 PLA2G6 XYLB PLEKHA7 TRIB1 ACSM2B | 2.53e-03 | 995 | 175 | 14 | EFO_0004518 |
| Disease | Adenocarcinoma of large intestine | 2.60e-03 | 96 | 175 | 4 | C1319315 | |
| Disease | fatty acid measurement, fetal genotype effect measurement, breast milk measurement | 2.61e-03 | 13 | 175 | 2 | EFO_0005110, EFO_0007959, EFO_0009092 | |
| Disease | triglyceride measurement, alcohol drinking | 2.90e-03 | 99 | 175 | 4 | EFO_0004329, EFO_0004530 | |
| Disease | Adenoid Cystic Carcinoma | 3.01e-03 | 100 | 175 | 4 | C0010606 | |
| Disease | fatty acid measurement, breast milk measurement, parental genotype effect measurement | 3.04e-03 | 14 | 175 | 2 | EFO_0005110, EFO_0005939, EFO_0009092 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 3.04e-03 | 14 | 175 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | triglyceride measurement, alcohol consumption measurement | 3.12e-03 | 101 | 175 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 3.28e-03 | 50 | 175 | 3 | EFO_0022303 | |
| Disease | head and neck squamous cell carcinoma (is_implicated_in) | 3.49e-03 | 15 | 175 | 2 | DOID:5520 (is_implicated_in) | |
| Disease | smoking status measurement | SEMA3F GAPVD1 CELF4 CDC42BPA WNT3 ZNF423 FAT3 CYP20A1 ADGRB3 SNX29 ADCY8 PALS2 ALK DNMT3B BRWD1 | 3.96e-03 | 1160 | 175 | 15 | EFO_0006527 |
| Disease | Diabetic Angiopathies | 3.97e-03 | 16 | 175 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 3.97e-03 | 16 | 175 | 2 | C0025945 | |
| Disease | level of Sterol ester (27:1/18:1) in blood serum | 3.97e-03 | 16 | 175 | 2 | OBA_2045195 | |
| Disease | urate measurement, bone density | CASP8AP2 SYNE1 ADGRB3 PSD3 LAMA5 SNX29 DOCK5 MARK4 C1QTNF9 DNAH11 | 4.01e-03 | 619 | 175 | 10 | EFO_0003923, EFO_0004531 |
| Disease | Mammary Carcinoma, Human | 4.27e-03 | 525 | 175 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 4.27e-03 | 525 | 175 | 9 | C1257931 | |
| Disease | serum metabolite measurement | PCYT1A CDC42BPA WNT3 SENP3 PTDSS1 PSD3 CPS1 DNAH17 SARDH ACSM2A TRIB1 ALK ACSM2B | 4.32e-03 | 945 | 175 | 13 | EFO_0005653 |
| Disease | Mammary Neoplasms | 4.37e-03 | 527 | 175 | 9 | C1458155 | |
| Disease | coronary artery disease, factor VII measurement | 4.37e-03 | 111 | 175 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | Antibody Deficiency Syndrome | 4.49e-03 | 17 | 175 | 2 | C0003257 | |
| Disease | factor VIII measurement, coronary artery disease | 4.66e-03 | 113 | 175 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | factor XI measurement, coronary artery disease | 4.96e-03 | 115 | 175 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | antihyperlipidemic drug use measurement | 4.96e-03 | 115 | 175 | 4 | EFO_0803367 | |
| Disease | Malignant neoplasm of breast | KDM3A MYH9 SYNE1 GPX4 ARAF CLASRP ABRAXAS1 TLE3 CLUL1 ALK TOP2A GOLGB1 AGAP2 DNMT3B | 4.96e-03 | 1074 | 175 | 14 | C0006142 |
| Disease | fibrinogen measurement, factor VII measurement | 4.98e-03 | 58 | 175 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | Breast Carcinoma | 4.99e-03 | 538 | 175 | 9 | C0678222 | |
| Disease | brain infarction | 5.03e-03 | 18 | 175 | 2 | EFO_0004277 | |
| Disease | keratinocyte carcinoma | 5.43e-03 | 118 | 175 | 4 | EFO_0010176 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 5.43e-03 | 118 | 175 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 5.48e-03 | 60 | 175 | 3 | EFO_0021898 | |
| Disease | HMG CoA reductase inhibitor use measurement | 5.50e-03 | 189 | 175 | 5 | EFO_0009932 | |
| Disease | platelet component distribution width | GAPVD1 MARK3 SYNE1 LAMA5 CPS1 DOCK5 MARK4 PLA2G6 TRIB1 BRWD1 SPIN3 | 5.59e-03 | 755 | 175 | 11 | EFO_0007984 |
| Disease | acetone measurement | 5.60e-03 | 19 | 175 | 2 | EFO_0010989 | |
| Disease | acute kidney failure (biomarker_via_orthology) | 5.74e-03 | 61 | 175 | 3 | DOID:3021 (biomarker_via_orthology) | |
| Disease | blood urea nitrogen measurement | 5.75e-03 | 452 | 175 | 8 | EFO_0004741 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 5.76e-03 | 120 | 175 | 4 | EFO_0004611, EFO_0004639 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SEGDTEKLKMYHSLL | 621 | Q15361 | |
| DGSLKEVHKINEMYA | 206 | Q6UWZ7 | |
| KDSSLEHKYSQMRDE | 696 | P40145 | |
| KDKSGEMALHVAARY | 441 | P53355 | |
| RVGGRDMQELKHKYD | 226 | Q9HCE6 | |
| SGMKHVETNTYDVKR | 121 | O75366 | |
| HKAGARVKIMDYEDF | 151 | Q96AK3 | |
| ALHEAVRHGSYKAMK | 246 | Q86SG2 | |
| TKDHAVDLIQKGYMR | 1041 | P0C0L5 | |
| AMYHALEKARVRAGK | 301 | Q9UBC3 | |
| DFIDAYLKEMSKHTG | 276 | P51589 | |
| KMADSAEKLREYGLS | 436 | Q8N7X0 | |
| KSRYSDLDFEKVMHT | 1416 | O60242 | |
| AEHSYSSLGLKAKMD | 231 | Q08AH3 | |
| SVEYQGVRKDFMAHK | 36 | Q9H116 | |
| GKEAMLKHRDYETAT | 431 | O43707 | |
| GHSLKNYMEEDESLK | 476 | Q49A92 | |
| VSAHRAVGMYSKEKE | 1671 | Q96DT5 | |
| DYIHSTHGKEMDLLR | 716 | Q99490 | |
| YAKVHMKDGSNRLQE | 266 | Q8N9N2 | |
| IYLASKMRKEHGTES | 176 | Q96AZ1 | |
| YKDRMKIGASLADVD | 401 | Q6PL18 | |
| LMSSYKVEAKGDTDR | 96 | Q7Z6K5 | |
| RTMREDYSDKVKASH | 216 | P21127 | |
| IYEFLKDASDKMGHS | 1626 | Q9UKL3 | |
| SLGYKKAEDEMSRAT | 31 | Q9NTI2 | |
| KSHFGRDLMTDLKSE | 406 | P08133 | |
| NYDVEHTIKKEMSGD | 571 | P08133 | |
| HTIKKEMSGDVRDAF | 576 | P08133 | |
| HMLERTKYENGISKV | 311 | Q9BYT9 | |
| KTAVEDSDKAYMLHI | 181 | Q9H939 | |
| DSDKAYMLHIGTLDK | 186 | Q9H939 | |
| HSDLMYIREKASAGS | 256 | Q9Y272 | |
| GMHYKRDLSIEEQSE | 166 | Q9UJ41 | |
| DHDSYGVDKKRKRGM | 401 | Q01201 | |
| VEMEKEKHSAERLYT | 271 | P05181 | |
| EKHSAERLYTMDGIT | 276 | P05181 | |
| SDSDDNIKRGKHMDF | 511 | Q96ST2 | |
| KHTYMRLDGSSKISE | 1141 | Q9ULG1 | |
| YKSELNKHIEDGMGR | 441 | Q8IWA4 | |
| RYEAKELHDAMKGLG | 96 | P13928 | |
| EKLKVSRDAKYSDHM | 391 | Q8N7Z5 | |
| MKALLGSYAHSVEDT | 211 | O14526 | |
| GDLHSDVTEAMLYEK | 16 | Q13310 | |
| HEDAMYGTKLETIRK | 811 | O14936 | |
| RDKEGHYIMVKGSIQ | 91 | O00370 | |
| KGVDAETMHTLLDYT | 116 | Q8WZ60 | |
| SEDLSDMHYRVKEKI | 416 | Q9HBG6 | |
| DMVEHYSKDKGAICT | 191 | P42679 | |
| VAEGMEYLESKKLVH | 336 | P42679 | |
| SKLLYHSDKEVMGDG | 1066 | Q14C86 | |
| DSELERKRKMVSFHG | 1341 | Q96Q04 | |
| LKKDRETMGHRYVEV | 71 | P55795 | |
| AGSDDVYKHIKEAGM | 176 | P49585 | |
| AGSDDVYKHIKEAGM | 176 | Q9Y5K3 | |
| MITASHNRKEDNGYK | 171 | Q6PCE3 | |
| MESHVFLKAKTRDEY | 41 | Q96RN5 | |
| EYFGKMLTERGHKLS | 161 | Q8IVH4 | |
| GHKLYMETKERIEQD | 431 | Q6ZN66 | |
| VRKISGHDTGKLYAM | 66 | O75582 | |
| SEEIVEMYKGKKRHE | 131 | P35579 | |
| YESKKRVSAEEAMKH | 456 | Q00537 | |
| TGDYMGVSLRDKKVH | 2791 | O15230 | |
| LKKDRETMGHRYVEV | 71 | P31943 | |
| LVRDASTKMHGDYTL | 356 | P27986 | |
| VFKYLGDKGVREHEM | 51 | Q8TCD6 | |
| VDSDHSGYISMKELK | 126 | Q9UBV8 | |
| LHSVMLEYTKDARSD | 3136 | P78509 | |
| KDLHMERVISYEEGK | 121 | Q15382 | |
| SRSEMEADIKAGKYL | 391 | Q9NZW5 | |
| VKILHTKDAYMSSED | 271 | P0C862 | |
| RDGMSVYDSLDKALK | 36 | P10398 | |
| AHIVLEDGTKMKGYS | 46 | P31327 | |
| EEAQKRESTTHMKAY | 2201 | Q3L8U1 | |
| SFHEDLRKLYKMAGV | 2481 | Q9C0G6 | |
| GTKYSMNHEGKRAEL | 461 | Q8N9C0 | |
| DAKFKEIRYRGMLHA | 41 | Q5SVS4 | |
| YHAVKDAVAMLKASE | 1301 | Q9Y4C1 | |
| RYEAKELHDAMKGLG | 96 | Q5VT79 | |
| EYHEGLKSNFRDMVK | 2011 | Q5JSL3 | |
| YVKLMKEDGTTLHDG | 531 | Q92608 | |
| RHDLVVYKGDNKKME | 566 | Q9H7D0 | |
| KYREGQEALMHTSSD | 676 | P0C221 | |
| HETERVYGDKMVDEK | 2686 | Q9UFH2 | |
| KDYSSDESIMESIKH | 761 | Q9HC77 | |
| LSKDHYMLIVKVSDG | 1946 | Q8TDW7 | |
| AHHRTMREDYSDKVK | 201 | Q9UQ88 | |
| VDKYRDGTKMVSADA | 71 | P09543 | |
| TGKLMDKSFSIRYHD | 1031 | Q9NSI6 | |
| DYLVAHGRMKEKEAR | 146 | Q9P0L2 | |
| EVFDYLVAHGRMKEK | 136 | Q7KZI7 | |
| FDYLVAHGRMKEKEA | 141 | P27448 | |
| YLVSHGRMKEKEARA | 146 | Q96L34 | |
| YDGMSVEAQSKHLAK | 2216 | Q8IWT3 | |
| MSHSYKKAISDEALR | 1 | Q96FQ7 | |
| ESYAMTSAHERKKPL | 6571 | Q8NDH2 | |
| SVSENHMRKKLYENG | 116 | Q6UW02 | |
| HMRKKLYENGVTDSL | 121 | Q6UW02 | |
| SAEYVGHLRATEKMK | 541 | Q9UBN7 | |
| AKDIDGHMVNLDKYR | 46 | P36969 | |
| TGNRMYHTKEKADEV | 121 | Q8IY37 | |
| DTGSSRMDRKHGKYI | 21 | Q8N1N2 | |
| TKDHAVDLIQKGYMR | 1041 | P0C0L4 | |
| KKRVYVMERLSAEGH | 1006 | O94851 | |
| EKPREMSKSYHDLSQ | 961 | Q12923 | |
| LKKDRESMGHRYIEV | 71 | P52597 | |
| IGLNMSKAHYEAEIK | 511 | Q92990 | |
| EMDSKSKDRITHYFI | 71 | Q96FC7 | |
| VKEGDHRKEAFSIGM | 356 | O95397 | |
| HNMDLVGDKATKESY | 251 | O14607 | |
| GSEYKEMEKLHRSLR | 751 | Q68CJ6 | |
| AMEDKSAEHKRTQYS | 221 | Q9UGI8 | |
| DKQYMHGIVRTKVDD | 351 | Q8TEU7 | |
| SSYERKLIEVAEMHG | 586 | Q8TEQ0 | |
| DTGHIYAMKILRKSD | 111 | Q9Y2H1 | |
| LKDEDHDRMYVGSKD | 61 | Q13275 | |
| KGHVMDRRKKALTDY | 161 | Q5TA31 | |
| KTEKMVHESSNRLYD | 3191 | Q8NF91 | |
| AEEKLKMYHSLAGSL | 4811 | Q8NF91 | |
| KMEESAEYEAARHKR | 301 | Q86TJ2 | |
| SKEDHENTEKYMGTE | 876 | Q5JRA6 | |
| GLEKDMQKTDIHYHS | 1756 | A0AVI2 | |
| KGKIETRHVAAMEKY | 331 | Q2TB90 | |
| TRHVAAMEKYKEGLA | 336 | Q2TB90 | |
| KMDDKSVPHEEYRSH | 306 | Q9P2K5 | |
| AKDKYRELAVEGMHR | 831 | Q9P2J5 | |
| SGMKEGVKRYEQEHA | 81 | Q9BRQ6 | |
| TEGKMYSLRERKGHA | 176 | Q9NQW5 | |
| KYAQDRASHLKMSSE | 496 | Q6IQ23 | |
| YTKEDGSKRIGMVIH | 216 | Q99865 | |
| AKASKETHVMDYRAL | 176 | Q9UL46 | |
| EEFLKREFGEHTKMT | 561 | O60733 | |
| YSDMKRALDKLDGTE | 156 | Q13247 | |
| EVTRMLKSKHGDNYL | 36 | Q68CZ2 | |
| EDIIMKYEKGHRAGL | 16 | B9A6J9 | |
| EKGTHKELMEERGRY | 681 | Q96J65 | |
| SLVETYGKIMNHKER | 286 | Q5VT25 | |
| KRLMSLGKAYGVESH | 166 | Q9UL12 | |
| TDYKMKKREAVDGHT | 411 | O00463 | |
| DYLHKDTGETSMLKR | 26 | Q9UHE8 | |
| AGHYEDTILKSKNSM | 1601 | Q9UM73 | |
| KSMEYVSRHAIDGKF | 336 | O00327 | |
| AEHSYSSLGLKAKMD | 231 | Q68CK6 | |
| YELTVLKDRFTGMHK | 81 | Q9BZC1 | |
| DAYMSKTKGHLDAEL | 221 | Q9Y3Y2 | |
| KTKGHLDAELDAYMA | 226 | Q9Y3Y2 | |
| HAKALEEEKAMYSGR | 251 | Q8N2M8 | |
| KHLEDTAYLVEKMRG | 366 | Q15846 | |
| IKKLMGSTEQYDHRH | 116 | Q8N782 | |
| EDIIMKYEKGHRAGL | 16 | A6NDS4 | |
| EDIIMKYEKGHRAGL | 16 | P0C7X1 | |
| VAYKRHVLTMDDLGT | 381 | Q9H4L4 | |
| YIDMTIKHGSQKDVR | 1801 | Q14690 | |
| MLEIHSQVKDKGYSE | 176 | Q9UM82 | |
| HYKKEGSERMTELAD | 441 | Q12768 | |
| EKDFGDMHSYVRSRK | 161 | Q96RU8 | |
| RAFHYDMKTEEGKLL | 286 | O95497 | |
| DIEQMLKLGSTSYHD | 371 | Q9Y6Q2 | |
| EDIIMKYEKGHRAGL | 16 | A6NER0 | |
| IREDMKYKDATNKHS | 96 | Q9P246 | |
| YAKDDGSKRTGMVIH | 216 | Q5JUX0 | |
| KEEHAIYTADLAMGT | 306 | Q9BSI4 | |
| YTKEDGSKRIGMVIH | 216 | Q9BPZ2 | |
| QEKAKRYHMDASGEA | 16 | Q8IX01 | |
| IHAEGLGYRVMSKTK | 421 | O75191 | |
| DKYDSASEMVVEKHR | 236 | P56703 | |
| VGDRLKEKYDSAAAM | 241 | Q9H1J7 | |
| LEIYSTGRMEKHLDA | 601 | Q8WVM7 | |
| IDSEGHSYMRRKTSK | 81 | Q96KF7 | |
| EDIIMKYEKGHRAGL | 16 | A0A087X179 | |
| DKMTRSHKNVADDYI | 231 | Q9Y5X3 | |
| HAIETEKMIEKYSGL | 296 | P11277 | |
| AEMELSDLIRKGYHK | 696 | Q13563 | |
| SEKHRGSADYSMEAK | 211 | Q04726 | |
| SKEAKEYFADMKRHR | 621 | P11388 | |
| RGAAEETKSLMKASY | 211 | O43247 | |
| EDIIMKYEKGHRAGL | 16 | A0A087WVF3 | |
| HFLKAARLDTYMGKV | 481 | Q6PGP7 | |
| MHKKRVEEGEASDFS | 1 | Q2M1K9 | |
| EHLQAEKSRMYVAKG | 181 | P35442 | |
| LSYVKEMTEGKRSSH | 266 | O75845 | |
| EDIIMKYEKGHRAGL | 16 | Q6DHY5 | |
| EDIIMKYEKGHRAGL | 16 | Q8IZP1 | |
| DTLKEAGTHYIMATD | 916 | Q9H4Z2 | |
| LERTAELYKGMTEHT | 156 | Q9NRD5 | |
| DNLKSMERGHKYDVF | 61 | Q86T29 | |
| GSRTLSKDDVNYKMH | 6 | P48651 | |
| VYKSGFLARKIHADM | 786 | Q9NYI0 | |
| EHSMVKEAALYTLGA | 71 | Q8NA31 | |
| YMSAQDGKAKTHISR | 381 | Q9H6P5 | |
| EDIIMKYEKGHRAGL | 16 | A0A087X1G2 | |
| KSEELLDMYGISARH | 571 | P51854 | |
| ASLAMKYSDVKLGDH | 56 | Q96QT4 | |
| VASEKHMGYDIDEVK | 481 | Q8IZ20 | |
| EDIIMKYEKGHRAGL | 16 | A0A087WXS9 | |
| EDIIMKYEKGHRAGL | 16 | Q6IPX1 | |
| DSLSYLKKVSMEGHL | 101 | Q6ICL3 | |
| NTDRIHIYTKDGKQM | 741 | Q5FWF4 | |
| REEVYMAAGHALRKK | 781 | Q5R3F8 | |
| KAHLEYRSAEMEKSK | 36 | Q309B1 | |
| SRYSALEQKHKAEME | 361 | Q14789 | |
| SMVKYHEDFEKTKGR | 781 | O76041 |